TD Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $120M | Sell |
239,981
-239,874
| -50% | -$115M | 0.1% | 166 |
|
|
2026
Q1 | $236M | Sell |
479,855
-217,833
| -31% | -$118M | 0.19% | 96 |
|
|
2025
Q4 | $404M | Buy |
697,688
+302,676
| +77% | +$171M | 0.33% | 61 |
|
|
2025
Q3 | $192M | Buy |
395,012
+5,388
| +1% | +$2.51M | 0.16% | 124 |
|
|
2025
Q2 | $158M | Sell |
389,624
-55,094
| -12% | -$23M | 0.13% | 147 |
|
|
2025
Q1 | $221M | Sell |
444,718
-41,480
| -9% | -$22.5M | 0.2% | 102 |
|
|
2024
Q4 | $253M | Sell |
486,198
-71,630
| -13% | -$39.4M | 0.22% | 92 |
|
|
2024
Q3 | $343M | Sell |
557,828
-44,739
| -7% | -$26.5M | 0.3% | 69 |
|
|
2024
Q2 | $333M | Buy |
602,567
+14,089
| +2% | +$8.07M | 0.31% | 69 |
|
|
2024
Q1 | $342M | Sell |
588,478
-177,505
| -23% | -$99.6M | 0.32% | 65 |
|
|
2023
Q4 | $407M | Sell |
765,983
-346,198
| -31% | -$168M | 0.4% | 56 |
|
|
2023
Q3 | $563M | Buy |
1,112,181
+87,910
| +9% | +$46.8M | 0.68% | 29 |
|
|
2023
Q2 | $534M | Buy |
1,024,271
+69,073
| +7% | +$37.3M | 0.61% | 35 |
|
|
2023
Q1 | $551M | Buy |
955,198
+8,111
| +0.9% | +$4.57M | 0.66% | 27 |
|
|
2022
Q4 | $522M | Buy |
947,087
+117,652
| +14% | +$62.3M | 0.64% | 31 |
|
|
2022
Q3 | $428M | Buy |
829,435
+228,567
| +38% | +$128M | 0.54% | 39 |
|
|
2022
Q2 | $326M | Buy |
600,868
+345
| +0.1% | +$190K | 0.38% | 54 |
|
|
2022
Q1 | $355M | Sell |
600,523
-15,040
| -2% | -$8.64M | 0.32% | 62 |
|
|
2021
Q4 | $411M | Buy |
615,563
+109,315
| +22% | +$68.3M | 0.34% | 66 |
|
|
2021
Q3 | $289M | Buy |
506,248
+843
| +0.2% | +$463K | 0.3% | 74 |
|
|
2021
Q2 | $273M | Sell |
505,405
-334,849
| -40% | -$158M | 0.28% | 80 |
|
|
2021
Q1 | $383M | Sell |
840,254
-50,791
| -6% | -$24.2M | 0.43% | 48 |
|
|
2020
Q4 | $415M | Sell |
891,045
-225,418
| -20% | -$106M | 0.5% | 44 |
|
|
2020
Q3 | $493M | Sell |
1,116,463
-44,648
| -4% | -$18.4M | 0.68% | 29 |
|
|
2020
Q2 | $421M | Buy |
1,161,111
+269,486
| +30% | +$90.3M | 0.6% | 34 |
|
|
2020
Q1 | $253M | Buy |
891,625
+60,855
| +7% | +$19.2M | 0.43% | 46 |
|
|
2019
Q4 | $270M | Buy |
830,770
+70,493
| +9% | +$21.4M | 0.39% | 52 |
|
|
2019
Q3 | $221M | Buy |
760,277
+60,064
| +9% | +$17.2M | 0.34% | 65 |
|
|
2019
Q2 | $206M | Buy |
700,213
+1,047
| +0.1% | +$288K | 0.31% | 63 |
|
|
2019
Q1 | $191M | Buy |
699,166
+232,950
| +50% | +$58M | 0.29% | 66 |
|
|
2018
Q4 | $104M | Buy |
466,216
+137,656
| +42% | +$32.3M | 0.18% | 106 |
|
|
2018
Q3 | $80.2M | Buy |
328,560
+23,193
| +8% | +$5.34M | 0.12% | 155 |
|
|
2018
Q2 | $63.3M | Sell |
305,367
-19,488
| -6% | -$4.14M | 0.1% | 174 |
|
|
2018
Q1 | $67.1M | Buy |
324,855
+14,916
| +5% | +$3.13M | 0.1% | 165 |
|
|
2017
Q4 | $58.9M | Sell |
309,939
-342
| -0.1% | -$65.5K | 0.09% | 184 |
|
|
2017
Q3 | $58.7M | Sell |
310,281
-8,775
| -3% | -$1.59M | 0.09% | 180 |
|
|
2017
Q2 | $55.7M | Sell |
319,056
-41,440
| -11% | -$6.96M | 0.09% | 184 |
|
|
2017
Q1 | $55.4M | Sell |
360,496
-20,440
| -5% | -$3.12M | 0.09% | 189 |
|
|
2016
Q4 | $53.8M | Sell |
380,936
-72,791
| -16% | -$10.7M | 0.09% | 187 |
|
|
2016
Q3 | $72.2M | Buy |
453,727
+2,097
| +0.5% | +$323K | 0.12% | 144 |
|
|
2016
Q2 | $66.7M | Sell |
451,630
-37,395
| -8% | -$5.52M | 0.12% | 149 |
|
|
2016
Q1 | $69.2M | Sell |
489,025
-25,803
| -5% | -$3.46M | 0.13% | 129 |
|
|
2015
Q4 | $73M | Buy |
514,828
+59,745
| +13% | +$7.97M | 0.14% | 126 |
|
|
2015
Q3 | $55.6M | Buy |
455,083
+94,200
| +26% | +$12.3M | 0.11% | 158 |
|
|
2015
Q2 | $46.8M | Buy |
360,883
+2,829
| +0.8% | +$369K | 0.08% | 193 |
|
|
2015
Q1 | $48.1M | Sell |
358,054
-8,877
| -2% | -$1.14M | 0.09% | 183 |
|
|
2014
Q4 | $46M | Sell |
366,931
-1,296
| -0.4% | -$158K | 0.08% | 193 |
|
|
2014
Q3 | $44.8M | Sell |
368,227
-3,432
| -0.9% | -$417K | 0.08% | 188 |
|
|
2014
Q2 | $43.9M | Sell |
371,659
-19,700
| -5% | -$2.32M | 0.07% | 186 |
|
|
2014
Q1 | $47.1M | Sell |
391,359
-167,300
| -30% | -$19.9M | 0.09% | 175 |
|
|
2013
Q4 | $62.2M | Buy |
558,659
+3,560
| +0.6% | +$354K | 0.12% | 144 |
|
|
2013
Q3 | $51.2M | Buy |
555,099
+9,800
| +2% | +$886K | 0.1% | 154 |
|
|
2013
Q2 | $46.1M | Buy |
+545,299
| New | +$45.4M | 0.1% | 158 |
|
Other funds holding TMO
VCM
VPM
TD Asset Management's TMO Position: Q2 2026 in Review
TD Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 50% in Q2 2026, selling an estimated $115M and leaving 239,981 shares worth $120M. The position accounts for 0.1% of the portfolio, ranked #166.
TD Asset Management first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $563M in Q3 2023. 2,215 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- TD Asset Management held 239,981 shares of Thermo Fisher Scientific worth $120M as of Q2 2026.
- TD Asset Management sold 239,874 Thermo Fisher Scientific shares in Q2 2026, an estimated $115M.
- Thermo Fisher Scientific made up 0.1% of TD Asset Management's portfolio in Q2 2026, its #166 holding.
- TD Asset Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
- TD Asset Management's Thermo Fisher Scientific position peaked at $563M in Q3 2023.
- 2,215 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.